The Antibody Drug Conjugates Market is expanding as oncology research increasingly focuses on targeted therapies that can selectively deliver potent drug payloads to cancer cells. ADCs combine antibody-based targeting with cytotoxic agents to create specialized treatment approaches. The Antibody Drug Conjugates Market size is projected to reach US$ 38,077.45 million by 2031 from US$ 8,105.65...